The Reality: DSIP Is Not an Approved Treatment DSIP is: Not FDA approved Not prescribed in addiction treatment programs Not included in clinical guidelines for opioid use disorder Even though it sounds promising on the surface, theres no strong evidence showing that DSIP can: Reduce cravings Prevent relapse Replace evidence-based treatments Its being discussed far more in online communities and experimental spaces than in real medical settings
While still in preclinical stages, the SOCS1 peptide represents an important conceptual advance in targeted autoimmune therapy
A research-market vial is not equivalent to study material A label stating DSIP or emideltide does not establish the exact peptide form, quantity, purity, aggregate level, microbiological quality or relationship to the material used in historical intravenous studies
Cell 173 , 12171230.e17 (2018)
[1] Outside this head-to-head, each ingredient has its own body of evidence
Such observations have also been seen in human liver cirrhosis [20]